<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
        {font-family:Verdana;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
        {font-family:"Comic Sans MS";
        panose-1:3 15 7 2 3 3 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
        {mso-style-priority:99;
        mso-style-link:"Balloon Text Char";
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:8.0pt;
        font-family:"Tahoma","sans-serif";}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
        {mso-style-priority:1;
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
span.BalloonTextChar
        {mso-style-name:"Balloon Text Char";
        mso-style-priority:99;
        mso-style-link:"Balloon Text";
        font-family:"Tahoma","sans-serif";}
span.EmailStyle20
        {mso-style-type:personal;
        font-family:"Verdana","sans-serif";
        color:windowtext;}
span.EmailStyle21
        {mso-style-type:personal-reply;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1029" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>See below for the e-newsletter & support group meeting reminder for PCCN Oakville-Mississauga.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Walter Eadie [mailto:walter.eadie@cogeco.ca] <br><b>Sent:</b> May 8, 2019 12:09 PM<br><b>To:</b> PC Support Group<br><b>Subject:</b> REMINDER - PC Support Group MAY 15th<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>                                <o:p></o:p></span></p><p class=MsoNormal><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="_x0000_s1027" type="#_x0000_t75" alt="Check out our website at https://www.pccn-oakville-mississauga.com/ " href="https://www.pccn-oakville-mississauga.com/" style='position:absolute;margin-left:197.6pt;margin-top:40.7pt;width:382.5pt;height:29.25pt;z-index:251661312;visibility:visible;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin' o:button="t">
<v:imagedata src="cid:image001.emz@01D505B9.D55AE450" o:title="" />
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:absolute;z-index:251661312;margin-left:263px;margin-top:54px;width:510px;height:39px'><a href="https://www.pccn-oakville-mississauga.com/"><img border=0 width=510 height=39 src="cid:image002.png@01D505B9.D55AE450" alt="Check out our website at https://www.pccn-oakville-mississauga.com/ " v:shapes="_x0000_s1027"></a></span><![endif]><!--[if gte vml 1]><v:shape id="_x0000_s1026" type="#_x0000_t75" alt="SUPPORT GROUP MEETING REMINDER" style='position:absolute;margin-left:162.2pt;margin-top:12.1pt;width:453pt;height:36.25pt;z-index:251659264;visibility:visible;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin' o:allowincell="f">
<v:imagedata src="cid:image011.emz@01D505B9.D55AE450" o:title="" />
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:absolute;z-index:251659264;margin-left:216px;margin-top:16px;width:604px;height:48px'><img width=604 height=48 src="cid:image012.png@01D505B9.D55AE450" alt="SUPPORT GROUP MEETING REMINDER" v:shapes="_x0000_s1026"></span><![endif]><b><span lang=EN-US><img width=161 height=99 id="Picture_x0020_5" src="cid:image003.jpg@01D4A7A6.07E62500" alt="cid:image001.jpg@01CDF27E.DB1D8B40"></span></b><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US>                                                                                                                </span><b><span lang=EN-US style='font-family:"Comic Sans MS"'><o:p></o:p></span></b></p><p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_s1028" type="#_x0000_t75" alt="Our next meeting (always the 3rd Wednesday, 7pm at 2545 Sixth Line, Oakville) " style='position:absolute;margin-left:131.75pt;margin-top:1.35pt;width:596.35pt;height:24.75pt;z-index:251663360;visibility:visible;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin'>
<v:imagedata src="cid:image013.emz@01D505B9.D55AE450" o:title="" />
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:absolute;z-index:251663360;margin-left:176px;margin-top:2px;width:795px;height:33px'><img width=795 height=33 src="cid:image014.png@01D505B9.D55AE450" alt="Our next meeting (always the 3rd Wednesday, 7pm at 2545 Sixth Line, Oakville) " v:shapes="_x0000_s1028"></span><![endif]><span lang=EN-US><img width=160 height=34 id="Picture_x0020_2" src="cid:image010.png@01D50596.CE9B86B0" alt="https://files.constantcontact.com/14b9ee0c501/1fd35007-cc89-46c2-b21b-1d880c92aee2.png"><o:p></o:p></span></p><p class=MsoNormal style='margin-left:288.0pt;text-indent:36.0pt'><span lang=EN-US style='font-size:14.0pt;font-family:"Verdana","sans-serif"'>is</span><b><span lang=EN-US style='font-size:18.0pt;font-family:"Verdana","sans-serif"'> May 15<sup>th</sup></span></b><span lang=EN-US><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>This month we will have two guests from our major sponsor <b>Astellas Pharma Canada</b>.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Lynne Vear is Senior Product Specialist and Jennifer Kitchen is Patient Access Manager.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Astellas is the Canadian distributor for Xtandi (enzalutamide) which has become widely used as ‘second generation hormone therapy’ for prostate cancer. We are very grateful for their financial support to our Group.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>While I am sure we will be able to learn a lot from them, this is will not be a commercial for their drugs. Instead, they will introduce our featured speaker <b>Robert Kulik from Patient Access Solutions</b> who will talk to us about the systems and processes for getting new drugs approved in Canada; who pays for the drugs; and how we as patients can get access to these drugs through our provincial drug plan or the “exceptional access program” or via clinical trials. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Drugs like Xtandi and Zytiga began life as ‘last resort’ therapy, to be used after even chemotherapy had failed. Now the studies are showing that these drugs, and newer versions (apalutamide, darolutamide), have value earlier and earlier in prostate cancer treatment. They are, however, many times more expensive than the first line ADT drugs such as Lupron, Zoladex, etc. so it’s important that we understand all we can about how to access them when we need them. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><br>This promises to be a great evening on a topic that is already applicable to some of our members and will be relevant to more of us as time goes by. As usual, there will be lots of time for questions and answers so come prepared.  <o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>Walter<o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><i><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'>P.S. If you have the time and want to know more about hormone therapy for prostate cancer, see below.<o:p></o:p></span></i></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;margin-left:36.0pt'><i><span lang=EN-US style='font-family:"Verdana","sans-serif"'>Dr. Andrew Loblaw from Sunnybrook will be speaking at PCCN-Brampton on Tuesday May 14<sup>th </sup>at 7 pm. <br>His topic will be “<b>Hormone Therapy for Prostate Cancer</b>”<br>I will be going and all are welcome to attend.(Wellspring Chinguacousy,5 Inspiration Way, Brampton).<br>Inspiration Way is just a short distance west of Torbram Road on the south side of Father Tobin Road<br></span></i><span lang=EN-US><a href="https://www.google.ca/maps/place/5+Inspiration+Way,+Brampton,+ON+L6R+0L7/@43.7705096,-79.7585175,17z/data=!3m1!4b1!4m5!3m4!1s0x882b17e98e8b0ea5:0x5b3e5729cb7ef7c4!8m2!3d43.7705057!4d-79.7563288?hl=en">https://www.google.ca/maps/place/5+Inspiration+Way,+Brampton,+ON+L6R+0L7/@43.7705096,-79.7585175,17z/data=!3m1!4b1!4m5!3m4!1s0x882b17e98e8b0ea5:0x5b3e5729cb7ef7c4!8m2!3d43.7705057!4d-79.7563288?hl=en</a></span><i><span lang=EN-US style='font-family:"Verdana","sans-serif"'><o:p></o:p></span></i></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-family:"Verdana","sans-serif"'>Also, don’t forget about the <i><a href="http://www.lifeonadt.com/">Online ADT Educational Program</a></i> which is still running – next session June 20<sup>th</sup>.   <o:p></o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr style='height:17.25pt'><td width=274 valign=top style='width:205.5pt;padding:2.25pt 2.25pt 2.25pt 2.25pt;height:17.25pt'></td></tr></table><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span lang=EN-US style='font-size:12.0pt;font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p></div></body></html>